More investments being made overseas in digital pathology for clinical use. This time within China using digital pathology for clinical applications including quality assurance.
MEDITE Joins UNIC Technologies in Key Alliance to Expand China’s Pathology Market
ORLANDO, FL, Aug 21, 2013 (Marketwired via COMTEX) — MEDITE Inc., a leading developer of innovative, high-quality equipment and supplies for histology, pathology and cytology laboratories, today announced that it has entered into a strategic alliance agreement with UNIC Technologies, a Chinese manufacturer of pathology scanners and tele-pathology services, to develop and deliver a full digital pathology and quality control solution for the Chinese market.
Under the terms of the agreement, effective August 15, 2013, MEDITE and UNIC have agreed to collaborative marketing, sales, engineering, technical development and commercialization of MEDITE’s pathology processing instruments in China under the National Digital Pathology and Quality Control (QC) project, which is funded by the central government in China.
In addition, MEDITE has been officially added to the China Association of Pathology Equipment (“CAPE”) as the primary provider of processing instruments and will be a key contributor in defining quality control procedures and criteria, as well as making the related industry standards in China.
“We are delighted to have been successful in positioning MEDITE in this high profile, key alliance with UNIC. This agreement provides a foundation that will enable MEDITE and UNIC to lead the digital pathology market in China, with the potential of making MEDITE the top process instruments brand in China, while supporting UNIC’s initiative to complete the QC project successfully and setting the standards for digital pathology in the future,” said Michaela Ott, co-president of MEDITE Group.”The digital pathology market in China is currently in its early adoption phase and expected to become the largest market in the world due to the population and government’s support for this initiative. Our team has developed a comprehensive product line of histology systems and supplies, and we look forward to collaborating with UNIC on this program as it is a tremendous step forward in MEDITE’s growth strategy.”
“Digital pathology is forcing process instrument and scanner companies to collaborate, so we are delighted to partner with MEDITE, giving us a distinct advantage over the competition as its products are known for quality, performance and value-added pricicing,” commented Ben Zheng, President of UNIC Technologies. “Our scanners are considered the best brand name in China, so coupled with our unparalleled resources, market knowledge and access, together, we will be able to deliver the highest quality process instruments to the Chinese market.”
In early September, MEDITE and UNIC are expected to officially launch the program at the CAPE event in Beijing. Through an initial series of marketing promotions and awareness activities, MEDITE will be positioned as the primary histopathology process instrument brand in China and the standard of choice in the pathology quality control project, with equipment and supplies delivered to all training centers national wide. Going forward, MEDITE and UNIC will closely collaborate on slide quality control and training. Moreover, UNIC is well positioned to establish the standards for digital pathology quality control.
In addition to the strategic alliance, MEDITE and UNIC also have agreed to consider the establishment of a joint venture to commercially market and sell products in China following the successful completion of the QC project. UNIC will be exclusively licensed to market and sell MEDITE’s histology systems and supplies in China.
About MEDITE Inc.
MEDITE Inc., a wholly-owned subsidiary of Burgdorf, Germany-based MEDITE(R) Group, is dedicated to serving customers in Europe, the U.S., Canada and Mexico. Since 1978, MEDITE(R) Group has specialized on the development, manufacture and distribution of medical laboratory equipment and supplies for pathology, histology and cytology. For these fields, the Company offers a complete range of devices and consumables. MEDITE Group currently sells into 70 countries and is the market leader in Germany. Through CytoGlobe, a wholly owned subsidiary, MEDITE offers a full range of products for Cytology labs, specifically liquid based cytology supplies and instruments.
Additional information on MEDITE’s products and services can be found at www.medite-group.com.
UNIC Technologies is an industry leader in integrated digital pathology solutions, which include pathology imaging solution enabling greater access for pathologists through industry-leading whole-slide-scanners, pathology network solution enabling remote, real-time viewing and easy distribution of images for collaboration, as well as pathology image analysis solution that provide pathologists with easy-to-use quantitative image analysis to improve clinical and research productivity, reproducibility and consistency. Striving to advance cancer diagnostics to improve patients’ lives, UNIC Technologies is expanding its capability in pathology processing with MEDITE providing a market-leading comprehensive product range for each step in the pathology process, from sample preparation and staining to reporting. UNIC Technologies is represented in all over China and other Asian countries.
Further information can be found at www.unictech.com.